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Background:Mutations in CFTR lead to CF, a lethal inherited disorder.
Results: The rescue of mutated CFTR affects its interaction with ENaC.
Conclusion: The mutated version of CFTR prevents its close association with ENaC unless F508-CFTR is rescued.
Significance:Thenature of theCFTR-ENaC interaction is important for themanagement of the airway pathology, which is now
the major cause of mortality for CF patients.
An imbalance of chloride and sodium ion transport in several
epithelia is a feature of cystic fibrosis (CF), an inherited disease
that is a consequence ofmutations in the cftr gene. The cftr gene
codes for a Cl channel, the cystic fibrosis transmembrane con-
ductance regulator (CFTR). Some mutations in this gene cause
the balance between Cl secretion and Na absorption to be
disturbed in the airways;Cl secretion is impaired,whereasNa
absorption is elevated. Enhanced Na absorption through the
epithelial sodium channel (ENaC) is attributed to the failure of
mutated CFTR to restrict ENaC-mediated Na transport. The
mechanism of this regulation is controversial. Recently, we have
found evidence for a close association of wild type (WT) CFTR
and WT ENaC, further underscoring the role of ENaC along
with CFTR in the pathophysiology of CF airway disease. In this
study, we have examined the association of ENaC subunits with
mutatedF508-CFTR, themost commonmutation inCF.Dele-
tion of phenylalanine at position 508 (F508) prevents proper
processing and targeting of CFTR to the plasma membrane.
When F508-CFTR and ENaC subunits were co-expressed in
HEK293T cells, we found that individual ENaC subunits could
be co-immunoprecipitated with F508-CFTR, much like WT
CFTR. However, when we evaluated the F508-CFTR and
ENaC association using fluorescence resonance energy transfer
(FRET), FRET efficiencies were not significantly different from
negative controls, suggesting that F508-CFTR and ENaC are
not in close proximity to each other under basal conditions.
However,withpartial correctionofF508-CFTRmisprocessing
by low temperature and chemical rescue, leading to surface
expression as assessed by total internal reflection fluorescence
(TIRF) microscopy, we observed a positive FRET signal. Our
findings suggest that the F508 mutation alters the close asso-
ciation of CFTR and ENaC.
Mutations in CFTR,3 the product of the cftr gene, lead to CF,
a lethal autosomal recessive disorder. Clinically, CF is charac-
terized by multisystem involvement; however, it is the airway
involvement that is the leading cause of morbidity and mortal-
ity (1–3). The mutations lead to the disruption of the CFTR
function as a Cl channel (4), which in turn interferes with
proper airway hydration. Because chloride secretion and
sodium absorption are responsible for the proper airway hydra-
tion, inadequate chloride secretion leads to sodium hyperab-
sorption. This sodium hyperabsorption, mediated by ENaC, is
believed to result from CFTRmutations changing the ability of
the protein to regulate sodium transport. The role of ENaCwas
further supported in mice that exhibited CF-like symptoms
when the -subunit of ENaC was overexpressed (5). We and
others have shown previously that the two transport molecules
are electrophysiologically coupled,where the presence ofCFTR
decreases the activity of channels formed by ENaCs.
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In our recent work, we documented the close association
between WT CFTR and ENaC subunits, showing with both
co-immunoprecipitation (co-IP) and FRET that there is an
interaction between these proteins (6). In this study, we inves-
tigated the association of ENaC subunits with the mutated var-
iant of CFTR,F508-CFTR.We found that all three ENaC sub-
units could be co-immunoprecipitated with F508-CFTR. The
results of our FRET findings, on the other hand, did not place
F508-CFTR and ENaC subunits in close proximity to each
other. However, both chemical and low temperature rescue of
F508-CFTR led to an observable FRET signal, placing these
two proteins in sufficiently close proximity to each other for a
direct association to take a place. Our biochemical findings
using co-IP are suggestive of an overall association between
mutated CFTR and ENaC subunits. In contrast, our FRET find-
ings suggest that the F508 mutation disrupts the close associ-
ation of CFTR and ENaC, leading to excessive ENaC activity.
EXPERIMENTAL PROCEDURES
Cell Culture—Cell culture andmaintenance were performed
as described previously (6). Briefly, human embryonic kidney
293T (HEK293T) cells (kind gift of Drs. K. Kirk and W. Wang,
University of Alabama at Birmingham) were maintained at
37 °Cwith 5%CO2, 95% air atmosphere in Dulbecco’s modified
Eagle’s medium (Invitrogen) with 10% fetal bovine serum
(HyClone, Logan, UT) and penicillin/streptomycin (100 IU/ml
and 100 g/ml, respectively; Invitrogen). Trypsin (Mediatech,
Herndon, VA) was used to subculture the cells a day before the
transient transfection. The cells were seeded on coverslips
(0.13–0.17 mm thick; Fisher) coated with 1:10 diluted poly-L-
lysine (Sigma).
Transient Transfection—Transient transfections were car-
ried out using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s recommended protocol. Briefly, 1 l of Lipo-
fectamine 2000 reagent (the DNA/Lipofectamine 2000 ratio
was 0.2 g/1 l) was incubated with 100 l of Opti-MEM I
(Invitrogen) at room temperature for 5 min. In a separate
Eppendorf tube, 0.2 g of each DNA construct was incubated
with 100 l of Opti-MEM I (Invitrogen). Following the 5-min
incubation time, the diluted DNA constructs and Lipo-
fectamine 2000 reagent were combined together and incubated
for another 20min. Then the transfection solutionwas added to
the cells in Opti-MEM I (without fetal bovine serum and anti-
biotics). After a 5-h incubation at 37 °C in a 5% CO2, 95% air
incubator, the transfection solution was changed to the regular
growth medium without antibiotics. Forty-eight hours post-
transfection, the cells were rinsed with phosphate-buffered
saline (PBS) (Invitrogen) and fixed for 15 min at room temper-
ature with 4% paraformaldehyde (prepared from 20% EM
Grade solution, Electron Microscopy Services, Hatfield, PA).
After fixation, the cells were rinsed three times with PBS and
mounted on glass microscope slides (Fisher) using 0.2% (w/v)
n-propyl gallate (Sigma) in 9:1 glycerol/PBS (v/v). The same
protocol was used to transfect the cells for co-IP experiments;
the DNA/Lipofectamine 2000 ratio was 1 g/2.5 l.
Generation of Fluorophore-tagged CFTR and ENaC cDNAs—
Generation of fluorophore-tagged CFTR and ENaC cDNAs was
described previously (6, 7). The CFTR with the enhanced green
fluorescent protein (EGFP-CFTR) fused to the N terminus was a
kind gift of Dr. B. Stanton (Dartmouth Medical School) (8). To
generate the CFTR construct tagged at its N terminus with the
enhanced cyan or yellow fluorescent protein (ECFP-CFTR or
EYFP-CFTR, respectively), theEGFPwasexchangedwithECFPor
EYFP following NheI/XhoI (New England Biolabs (Ipswich, MA)
or Promega (Madison,WI)) digestion and ligation (6). TheF508
mutation was introduced into CFTR to generate F508-CFTR
N-terminally tagged with enhanced cyan fluorescent protein
(ECFP-F508-CFTR). The human chloride channel 1 (ClC-1)
taggedN-terminally (9)withECFP(ECFP-ClC-1)wasakindgiftof
Dr. ChristophFahlke (Institut fürNeurophysiologieMedizinische
Hochschule Hannover, Hannover, Germany).
ENaC Antibodies—Rabbit polyclonal antibodies (Abs) were
generated (6) against synthetic peptides in collaboration with
Drs. Mark Knepper and Patricia A. Gonzales (National Insti-
tutes of Health, Bethesda, MD).
Western Blot Analysis of CFTR and ENaC (10, 11)—
HEK293T cells were transfected with 2 g of ECFP-CFTR con-
struct. Forty-eight hours post-transfection, cells were lysed with
radioimmunoprecipitation assay buffer (Pierce) complemented
with Complete protease inhibitor mixture (Roche Applied Sci-
ence) at 4 °C. After centrifugation (15,800  g for 10 min at 4 °C),
non-solublematerial was discarded. 100g of total cell lysate was
subjected to 6% SDS-PAGE (Invitrogen), followed by transfer to
polyvinylidene difluoride (PVDF) membrane (Bio-Rad) that was
probed with 1:10,000 diluted polyclonal Ab against the second
nucleotide binding domain of CFTR (kind gift ofDr. J. Hong,Uni-
versity of Alabama at Birmingham Cystic Fibrosis Research Cen-
ter). Detection was accomplished using a secondary anti-rabbit
antibody conjugated to horseradish peroxidase (HRP) (Dako) and
chemiluminescence. Western blot analysis of tagged ENaC con-
structs was as described previously (6).
F508-CFTR and ENaC Co-IP Experiments—F508-CFTR
and ENaC co-IP experiments were performed following a pro-
tocol described previously (11). Briefly, theHEK293T cells were
transfected with CFTR and appropriate combinations of ENaC
subunits and incubated for 48 h. The cells then were lysed with
0.2% Triton X-100 in PBS with Complete protease inhibitor
mixture (Roche Applied Science) at 4 °C. The cell lysates were
centrifuged at 15,800  g for 10 min at 4 °C; the non-soluble
material was discarded. The supernatant was incubated for 2 h
with 1 g of carboxyl-terminal CFTR monoclonal Ab clone
24–1 (R&D Systems, Minneapolis, MN) cross-linked to A/G-
agarose beads (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA). Then the beads were pelleted and rinsed three times in
PBS with 1% Triton X-100. Immunoprecipitated CFTR and
boundproteinswere analyzed on SDS-PAGEand transferred to
a PVDF membrane, and the samples were processed for West-
ern blotting using Abs raised against ENaC and CFTR (R&D
Systems).
Surface Co-IPAssay—Acombination of surface biotinylation
and co-IP (12) was used to identify changes in surface expres-
sion following low temperature rescue. HEK293T cells were
co-transfected with F508-CFTR and all three ENaC subunits
(one of the three subunits in -ENaCwas tagged with EYFP-
-EYFP-,-EYFP-, and -EYFP-). The cells were incu-
bated at 27 °C for 48 h after an initial 24-h incubation at 37 °C.
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The cells werewashed three timeswith ice-cold PBS containing
1mMMgCl2 and 0.1mMCaCl2 and incubatedwith sulfosuccin-
imidyl 2-(biotinamido)-ethyl-1,3-dithiopropionate (Pierce; 1.5
mg/ml in ice-cold PBS) for 30 min at 4 °C. The cells were then
washed twice with freshly prepared quenching solution (50mM
glycine in PBS) and lysed by radioimmunoprecipitation assay
buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxy-
cholate, 0.1% SDS, and 50mMTris, pH 7.4) with protease inhib-
itor mixture tablets (Roche Applied Science). Cell lysates were
homogenized by passing fifty times through a 22-gauge needle
and centrifuged (13,200 rpm, 30 min at 4 °C). Protein concen-
tration of the supernatant was measured using the bicin-
choninic acid (BCA) protein assay (Pierce). Immunoprecipita-
tion of CFTR was done by adding 4 g of anti-mouse CFTR
antibody to 2000 g of protein cell lysate overnight at 4 °C.
After washing three times with lysis buffer, Protein G beads
(100 l; Pierce) were added to the antibody-lysate complex and
incubated overnight at 4 °C. Beads were collected after centri-
fuging the lysates at 5000 rpm for 5min andwashed three times
with lysis buffer. After removing residual buffer, bead-IP-CFTR
interactionswere disrupted by incubating the beadswith 150l
of 1% SDS for 2 h at 37 °C. The sample was centrifuged at 5000
rpm for 5 min, and the supernatant was mixed with 450 l of
lysis buffer. After washing three times with lysis buffer, strepta-
vidin beads (100 l; Pierce) were added to the samples and
incubated overnight at 4 °C. The beads were collected as
described above. After removing residual buffer, samples were
heated at 95 °C for 6 min in 1 Laemmli sample buffer (25%
glycerol, 2% SDS, 0.01% bromphenol blue, 10%-mercaptoeth-
anol, 62.5 mM Tris HCl, pH 6.8) and subjected to SDS-PAGE
over 10% separating gels. Following transfer, membranes were
blocked for 1 h with 5% bovine serum albumin (BSA) in Tris-
buffered saline (100 mM Tris (pH 7.5), 150 mM NaCl), with
Tween 20 (0.1%; Bio-Rad) (TBS-T) at room temperature and
probed with mouse anti-GFP monoclonal antibody (Abgent,
SanDiego, CA) at 1:2000 in 5% BSA in TBS-T overnight at 4 °C.
FRET Imaging—For FRET measurements, an acceptor pho-
tobleaching technique was utilized as described previously (7,
13). Briefly, an upright DMRXE Leica Confocal Scanning Sys-
tem (Exton, PA) TCS SP2with an argon laser,100 1.4 numer-
ical aperture plan apochromatic oil immersion objective was
used for imaging. ECFP and EYFP fluorescence were excited
with 458- and 514-nm laser light, respectively; a dual dichroic
(DD458/514) was used in the excitation path. The emissions for
ECFP and EYFP were collected using 465–505-nm and 525–
600-nm band pass windows, respectively. Fixed samples were
imaged within 3 days. We noticed an increase in background
fluorescence if fixed samples were processed after a longer
period (more than 7–10 days) of storage. The regions of interest
in cells expressing both fluorophoreswere photobleachedusing
514-nm laser light to 30% of original intensity. ECFP and EYFP
images were taken both before and after acceptor photobleach-
ing. FRET efficiency (E) was calculated using Leica software,
EDpostDpre/Dpost, whereDpre andDpost are ECFP emission
before and after regional photobleaching, respectively.
FLIM Imaging—HEK293T cells seeded on glass bottom
dishes (In Vitro Scientific, Sunnyvale, CA) were transfected
with appropriate constructs (see “Transient Transfection”).
FLIM measurements were carried out on a Zeiss 710 confocal
microscope (Carl Zeiss MicroImaging, Thornwood, NY)
equipped with Becker & Hickl GmbH (Berlin, Germany) time
domain FLIM system. The excitation source was a 405-nm
picosecond pulsed diode laser with a 50-MHz repetition rate
and a pulse width of around 70 ps integrated into the Zeiss
confocal system. The fluorescence decay curves were analyzed
using SPC Image software (Becker & Hickl). The apparent
mean lifetime (Tm) of the donor was derived from double expo-
nential fit of the decay curves. An apparent FRET efficiency (E)
was calculated according to the equation, E  1  (TFRET/
TECFP-CFTR). The difference between groups was calculated
using Student’s two-tailed test; the significance was set at p 
0.05.
TIRF Imaging—The imaging was carried out with HEK293T
cells transfected with CFTR constructs at room temperature of
25 °C as described previously (14). Briefly, the cell growth
medium was changed to a solution that contained 140 mM
NaCl, 5 mM KCl, 2 mM CaCl2, 2 mMMgCl2, 10 mMHEPES, and
5 mM glucose (pH 7.4) before the start of the imaging. The
inverted IX81 Olympus microscope (Center Valley, PA) outfit-
tedwith differential interference contrast, wide field epifluores-
cence, and total internal reflection fluorescence illumination
was used for imaging. Images were captured with a 60 plan
achromatic oil immersion TIRF microscope objective with a
numerical aperture of 1.45 using a CoolSNAP-HQ-cooled,
charge-coupled device camera (Roper Scientific, Tucson, AZ)
controlled byMetamorph imaging software version 7.0 (Molec-
ular Devices, Sunnyvale, CA). The laser beam was brought to
the correct angle for total internal reflection by focusing it on
the outer edge of the objective’s rear aperture. The light source
was an argon laser (10milliwatts at 488nm,MellesGriot (Carls-
bad, CA)). For epifluorescence visualization of EYFP and ECFP,
we used standard fluorescein/FITC and ECFP filter sets; a
xenon arc lamp (100 watts) was used as a light source. All
images shown in the figures represent pseudocolored raw data
with their pixel intensities without saturation and within the
camera’s dynamic range (0–4095).
RESULTS
Analysis of Fluorophore-tagged Constructs—Western blot
analysis demonstrated that the fusion of a 27-kDa fluorescent
tag (ECFP or EYFP) to CFTR and F508-CFTR did not affect
our ability to immunoprecipitate or detect the protein (Fig. 1A)
(6). Also, fusion of the fluorescent tag to theWT CFTR did not
interfere with its trafficking as evidenced by predominant
plasma membrane delineation of the staining (supplemental
Fig. S1A) (6, 8) or Cl channel function (6, 8). In contrast,
tagged F508-CFTR constructs show predominant intracellu-
lar staining without plasma membrane delineation (supple-
mental Fig. S1B), suggestive of the impaired trafficking charac-
teristic of this CFTR mutant (15).
We have previously shown that Western blot analysis of
tagged ENaC revealed the expected bandsmatching themolec-
ular weight of the ENaC subunits with the fluorescent tags (6).
When tagged ENaC subunits were expressed in cells, micros-
copy showed amore prevalent ER staining; this pattern of stain-
ing is characteristic of ENaC constructs and indicates poor traf-
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ficking (6). Nevertheless, functional currents with typical ENaC
characteristics were recorded from cells transfected with
tagged ENaC constructs (7, 16, 17).
ENaC Subunits Interact with F508-CFTR by IP—The
recent electrophysiological findings (18), co-IP data (6), and
FRET results (6) have suggested a close association between
WT CFTR and ENaC. Here, we assessed a physical interaction
between the mutated version of CFTR (F508-CFTR) and
ENaC. HEK cells were transfected with wild-type or F508
CFTR alone or in combination with -ENaC, and then indi-
vidual ENaC subunits were probed with appropriate subunit
specific antibodies. Forty-eight hours later, the cells were lysed
and immunoprecipitated with a C-terminal CFTR antibody,
separated by SDS-PAGE, and transferred to PVDF membrane.
Blotswere incubatedwith antibodies directed against either the
C terminus of CFTR or each individual ENaC subunit. As
shown in (Fig. 1, B–D), ENaC subunits were only co-precipi-
tated with CFTR in cells expressing both proteins, suggesting
that F508-CFTR and ENaC can associate with each other. No
co-IP was observed when either F508-CFTR or ENaC was
omitted. These findings were comparable with WT CFTR and
ENaC association studies (Fig. 1, B–D) (6).
F508-CFTR is a processing mutation that interferes with
folding and trafficking of CFTR, resulting in retention of
mutant protein in ER. The effects of this mutation can be par-
tially reversed with low temperature (19) incubation of the
mutant CFTR. We have combined surface biotinylation with
co-IP (12) to evaluate the cell surface co-IP signal of F508-
CFTR and ENaC subunits following the low temperature cor-
rection. F508-CFTR and all three ENaCs (one of three sub-
units in -ENaC was tagged with EYFP in each case) were
co-transfected, and then each individual ENaC subunit was
probed. Compared with the 37 °C incubation (Fig. 2, left side of
each panel), the low temperature incubation at 27 °C (Fig. 2,
right side of each panel) enhanced the co-IP signal, which was
statistically significant (Fig. 2, corresponding bar graphs).
These data suggest that the low temperature rescue of F508-
CFTR enhances the F508-CFTR and ENaC surface co-IP
signal.
Next, we explored the possibility that the random aggrega-
tion as a result of overexpression could lead to co-IP of ENaC
with F508-CFTR. The lysates of the cells expressing -ENaC
were mixed with the lysates of the cells expressing F508-
CFTR; no co-IP signal was observed, indicating that association
of -ENaC and F508-CFTR did not occur postlysis (Fig. 3A).
As another control, we performed the co-IP experiment with
F508-CFTR and another channel, ECFP-ClC-1. As Fig. 3B
demonstrates, no co-IP signal was observed between F508-
CFTRandECFP-ClC-1. The anti-GFPmonoclonalAb JL-8 (BD
Living Colors), which also recognizes CFP, was used to confirm
the expression of ECFP-ClC-1 in the cells (Fig. 3B). Our find-
ings indicate that F508-CFTR and ENaC can associate with
FIGURE 1. Western blot analysis of tagged CFTR constructs. A, the blot was carried out using a polyclonal Ab raised against the NBD2 domain of CFTR and
probed with an anti-rabbit HRP using chemiluminescence. ENaC subunits interact with both WT and F508 CFTR. -ENaC (B), -ENaC (C), and -ENaC (D) could
be co-immunoprecipitated using a C-terminal CFTR antibody when co-expressed with F508-CFTR; -ENaC and F508-CFTR were co-expressed, and then
individual subunits were probed. No ENaC signal was detected when -, , or -ENaC or F508-CFTR was expressed alone. The left panels show that -, , or
-ENaC can only be detected when expressed in HEK-293 cells. Therefore, ENaC subunits are not endogenously expressed in those cells. These experiments
were repeated at least three times, and similar results were obtained.
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each other in a specific manner when co-expressed in
HEK293T cells.
FRET Measurements by Acceptor Photobleaching—Next, we
utilized FRET imaging to assess the association between
F508-CFTR and ENaC. FRET can only be observed when flu-
orescent donor and acceptor proteins are less than 10 nm apart
(20–22). In the acceptor photobleaching mode of FRET,
bleaching of the acceptor will result in an increase in donor
fluorescence if FRETwas occurring prior to bleaching (13). The
ratios of the donor (ECFP) fluorescence emission before and
after selective photobleaching of the acceptor are used to cal-
culate an apparent FRET efficiency (E).
As in our studies previously described (6), cells transfected
with ECFP-linker-EYFP fusion protein served as a positive con-
trol, whereas cells transfected with separate ECFP and EYFP
constructs served as a negative control for FRET (supplemental
Fig. S2). A 514-nm laser was used to bleach the regions of inter-
est. Images of ECFP and EYFP were taken before and after
selective photobleaching of the acceptor. The ECFP-EYFP
fusion construct (positive control) demonstrated 30% FRET
efficiency, whereas our negative control yielded less than 2%
(Fig. 4 and supplemental Fig. S2).
The HEK293T cells were transfected with ECFP-F508-
CFTR and all three ENaC subunits; one of the three subunits
carried EYFP as a tag. Supplemental Fig. S3 depicts a set of
before and after images obtained following a selective bleaching
of an acceptor (ENaC subunit tagged at the C terminus with
EYFP). The green box shows the area of bleaching. We did not
find an increase in CFP fluorescence after selective bleaching of
the acceptor; the energy transfer efficiency values (3%) were
not significantly different from those of the negative controls
(2%, p 0.44). A bar graphwith a summary of E values for all
combinations of tagged ENaC and ECFP-F508-CFTR is given
in Fig. 4. Thesemeasurements indicate that FRETdid not occur
between F508-CFTR and any ENaC subunits, suggesting that
the misfolding of the F508-CFTR prevents its close associa-
tion with ENaC. As mentioned previously, we found an appre-
ciable increase inCFP fluorescence after selective photobleach-
ing with all combinations of ENaC and WT CFTR; the energy
transfer efficiency values averaged7% (p 0.05), but values as
high as 17% were observed (6).
Previous studies have shown that low temperature (19) and
some chemical correctors (23–27) can partially improve the
folding and consequently trafficking of the F508-CFTR (28–
32). Because our model, based on lipid bilayer studies, shows a
functional interaction between the two proteins at the bilayer,
intracellularly retained F508-CFTR may not have a similar
interaction with ENaC because the surface expressed F508-
CFTR. We therefore attempted further FRET experiments in
cells transfected withF508 and exposed to either low temper-
FIGURE 2. Evaluation of the changes in surface expression following low
temperature rescue of F508-CFTR. A combination of surface biotinylation
and co-IP was utilized to monitor changes in surface expression. The cells
were co-transfected with F508-CFTR and all three ENaC subunits; one of
three subunits in -ENaC was tagged with EYFP - -EYFP- (A), -EYFP-
(B), and -EYFP- (C). The low temperature rescue enhanced the co-IP signal
and was statistically significant (*, p  0.05; **, p  0.01; ***, p  0.001; corre-
sponding densitometry bar graphs). The changes in densitometry value at
27 °C were normalized to that at 37 °C (100%). The bands at 56 kDa in each
panel indicate the high molecular weight immunoglobulin band. These
experiments were repeated at least three times with similar results. Error bars,
S.E.
FIGURE 3. A, -ENaC and F508-CFTR co-IP signal does not occur postlysis.
The lysates of cells expressing -ENaC were mixed with the lysates of cells
expressing F508-CFTR; immunoprecipitation was carried out with a C-ter-
minal CFTR antibody, followed by blotting with -ENaC subunit-specific anti-
body. B, F508-CFTR does not interact with the Cl channel ECFP-ClC1 follow-
ing co-expression in HEK-293T cells. An anti-GFP monoclonal Ab JL-8 (BD
Living Colors), which recognizes ECFP, was used to blot for ECFP-ClC-1. No
co-IP signal was detected in IP of cells co-expressing the F508-CFTR and
ClC-1 (bottom panel, far right lane).
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ature or chemical correctors. Recently, Robert et al. (33)
reported that glafenine, an anthranilic acid derivative, was able
to partially correct F508-CFTR misprocessing in several in
vitro model systems. We therefore used glafenine for our
F508-CFTR and ENaC FRET experiments. We found that
glafenine (10 M in DMSO, 48-h incubation) resulted in a pos-
itive FRET signal (11% versus 3% in negative controls, p 
0.003) between F508-CFTR and ENaC subunits (supplemen-
tal Fig. S4 and summary bar graph in Fig. 5A); this treatment,
however, does not affect positive and negative FRET controls
(Fig. 5A, bars 1 and 2). Next, we attempted FRET measure-
ments between F508-CFTR and ENaC following low temper-
ature (27 °C for 48 h after an initial 24-h incubation at 37 °C
following transfection) rescue of F508-CFTR (supplemental
Fig. S5 and summary bar graph in Fig. 5B). Again, we were able
tomeasure a significant FRET signal (13% versus2% in neg-
ative controls,p 0.009) betweenF508-CFTRandENaC sub-
units (supplemental Fig. S5); this treatment does not affect pos-
itive and negative FRET controls (Fig. 5B).
Additionally, we attempted the FRETmeasurement between
F508-CFTR and ENaC subunits following the rescue by a
combination of Corr3a and Corr4a (supplemental Fig. S6 and
summary bar graph in Fig. 5C). Corr3a (quinazoline com-
pound) and Corr4a (thiazole compound) are small molecules
that act as pharmacological chaperones, promoting the folding
and trafficking of F508-CFTR (28–32). However, the inter-
pretation of these FRET findings was complicated by the fact
that with these “specific” correctors, we observed increased
FRET efficiency in our negative FRET controls (10% com-
pared with 2% without the correctors). This interesting find-
ing is probably due to the specificity andmechanismof action of
these correctors, suggesting that perhaps a GFP-based FRET
assay might be useful to screen/identify novel correctors.
Next, we examined the specificity of our positive FRET signal
between F508-CFTR and ENaC subunits following partial
correction of F508-CFTR by low temperature and chemical
correctors. For this purpose, we repeated our low temperature
and chemical correction experiments with ECFP-ClC-1 and
ENaC subunits. Supplemental Fig. 7A demonstrates the life-
time images of cells expressing positive (ECFP and EYFP fusion
construct; left) and negative FLIM controls (ECFP and EYFP
constructs co-expressed separately; right); the decrease in the
mean ECFP lifetime to 0.8 ns (left) from 2.5 ns (right) indicates
the energy transfer from ECFP to EYFP. Supplemental Fig. 7B
demonstrates the lifetime images of cells expressing ClC-1
tagged with ECFP. In the absence of ENaC tagged with EYFP,
themean lifetime of ECFP tagged to ClC-1 averaged around 2.3
ns before (supplemental Fig. S7B, far left panel labeled 37 °C)
and following low temperature and chemical correction (sup-
plemental Fig. S7B, panels labeled 27 °C, glafenine,Corr3a, and
Corr4a).Wedid not observe a decrease in the donor lifetime, an
indication of FRET taking place, when ECFP-ClC-1 was co-ex-
pressed with any ENaC subunit tagged with EYFP (supplemen-
tal Fig. S8, A–C). The mean ECFP lifetime tagged to ClC-1 (in
the presence of any EYFP-tagged ENaC) was 2.2–2.5 ns, not
significantly different from that in the absence of EYFP (p 
FIGURE 4. Apparent FRET efficiencies, E, obtained after acceptor photo-
bleaching of HEK293T cells co-transfected with vectors encoding ECFP-
F508-CFTR and -ENaC (in -ENaC, one each of the three sub-
units tagged at the C terminus with EYFP). Also, E is shown for control
constructs. Error bars, S.D. of at least five cells imaged.
FIGURE 5. Apparent FRET efficiencies, E, obtained after acceptor photo-
bleaching of HEK293T cells co-transfected with vectors encoding ECFP-
F508-CFTR and -ENaC (in -ENaC, one each of the three sub-
units tagged at the C terminus with EYFP) following the partial
correction by glafenine (A), low temperature (B), and combination of
Corr3a and Corr4a (C). Also, E is shown for control constructs. Errors bars, S.D.
of at least five cells imaged.
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0.1); Fig. 6 demonstrates a summary bar graph of energy trans-
fer efficiencies under different conditions. Taken together, the
presence of a FRET signal betweenF508-CFTR andENaC and
its absence betweenClC-1 and ENaC following the low temper-
ature and chemical correction further strengthens the specific-
ity of energy transfer between F508-CFTR and ENaC
subunits.
TIRF Microscopy—We next assessed the trafficking of
F508-CFTR following low temperature and chemical rescue
by utilizingTIRFmicroscopy. This approach allows the study of
taggedmolecules near or at the plasmamembrane. Data shown
in supplemental Fig. S9 show TIRF images of cells transfected
either withWT (supplemental Fig. S9A) or F508-CFTR (sup-
plemental Fig. S9B) tagged on the N terminus with EYFP. The
pattern of F508-CFTR expression shows predominant cyto-
plasmic distribution indicative of various membrane-bound
organelles (supplemental Fig. S9B; inset depicts the epifluores-
cence image of the same cell) as compared with a staining pat-
tern closer to or at the plasma membrane of WT CFTR (sup-
plemental Fig. S9A; inset depicts the epifluorescence image of
the same cell). Rescue by low temperature and chemical correc-
tors resulted in an improved membrane distribution of F508-
CFTR (supplemental Fig. S10); interestingly, the combination
of the low temperature and chemical correctors had a more
pronounced effect on F508-CFTR (supplemental Fig. S10D)
near or at plasma membrane expression. These TIRF results
verify that low temperature and chemical rescue improves the
trafficking of F508-CFTR.
DISCUSSION
In our recent study (6), we demonstrated the close associa-
tion betweenWTCFTR and ENaC subunits using biochemical
and FRET approaches. In this study, we probed the possible link
between the most common disease-causing variant of CFTR,
F508-CFTR, and ENaC. Our co-IP findings are suggestive of a
physical association betweenF508-CFTR and ENaC subunits.
However, our FRET findings indicate that the mutated version
of CFTR prevents a close association between F508-CFTR
and ENaC unless F508-CFTR is rescued by low temperature
and chemical correctors.
The co-IP of the two transport molecules would, at first, sug-
gest that there is some direct interaction between the two pro-
teins. It has often been argued that in overexpression systems,
the presence of an interaction as detected by co-IP is an artifact
due to the superphysiological levels of the two proteins. How-
ever, as we showed previously with WT CFTR (6), the interac-
tion of F508-CFTR is specific for the ENaC subunits because
we do not see an interactionwith another transport protein, the
chloride channel ClC-1. Because F508-CFTR is poorly traf-
ficked secondary to theF508mutation and it is well described
thatWT ENaC subunits are poorly trafficked (16, 34), it is pos-
sible that the co-IP interaction occurs in the ER or during tar-
geting for degradation or retention. This idea is supported by
the knowledge that CFTR expression alters ENaC trafficking.
Although testing this would be challenging, it is a good example
of the weaknesses of co-IP to either rule in or rule out a direct
physical interaction. Although a positive signal validates that in
these conditions the two proteins are in some complex
together, it does not necessitate a direct physical interaction,
and similarly a negative signal would not rule out the possibility
that there is never a direct physical interaction.
Conversely, FRET cannot occur beyond the physical limit of
10 nm, with FRET efficiency changing dependent on the rela-
tive positions of the fluorescent tags (35). Our FRET findings
did not place the fluorescent tags on F508-CFTR in suffi-
ciently close proximity to the fluorescent tags on ENaC for an
association to occur, and the identity of ENaC subunits did not
change the efficiency of energy transfer (Fig. 4). The simple
interpretation of these data is that the deletion at residue posi-
tion 508 prevents the close association of CFTR and ENaC.
Indeed, this fits well with the pathogenesis of CF airway disease,
which postulates that the mutation prevents the down-regula-
tion of ENaC by CFTR (1). This CFTR-mediated inhibition of
ENaC activity might involve the gating (18) of ENaC and/or the
FIGURE 6. Apparent FRET efficiencies, E, obtained following fluorescence
lifetime measurements of HEK293T cells co-transfected with vectors
encoding ECFP-ClC-1 and -ENaC (in -ENaC, one each of the three
subunits tagged at the C terminus with EYFP) with no treatment (A) and
following partial correction by low temperature (B) and glafenine (C).
Not shown are the results of the partial correction with Corr3a and Corr4a.
Also, E is shown for control constructs. Error bars, are S.D. of at least three cells
imaged.
F508 CFTR and ENaC Link
MAY 11, 2012 • VOLUME 287 • NUMBER 20 JOURNAL OF BIOLOGICAL CHEMISTRY 16787
protection of ENaC from proteolysis (36) that activates near
silent ENaCs (37). These possibilities are not mutually exclu-
sive; the close proximity or direct physical association of CFTR
with ENaC conceivably might represent a step to protect the
ENaC subunits from proteolysis and subsequent activation.
It is possible that the physical targeting of F508-CFTR is
different from that of ENaC subunits, which effectively pre-
vents FRET. For example, ENaCmight be predominantly at the
surface while F508-CFTR is retained intracellularly, but per-
haps if both were at the surface, the two could interact directly
and be observed by FRET. However, this is not the case because
a fluorescent signal was clearly visible for both proteins inside
the cell and at the surface (supplemental Fig. S3, A–C). The
energy transfer efficiencies measured in delineated plasma
membrane versus broad regions of interest across the cells were
not significantly different from each other (Fig. 4 and supple-
mental Fig. S3,A–C). Interestingly, the lack of FRET signal with
theF508-CFTR (without the partial rescue by the low temper-
ature and chemical correctors) also validates that the FRET
signal between WT CFTR and ENaC was not due to overex-
pression, tight packing, or some other artifact as could have
been conjectured with our prior work (6).
Of note, however, our prior work showed WT CFTR and
ENaC to FRET intracellularly as well as at the surface (6). The
lack of FRET shows that there is some significant difference
between the interactions of the F508-CFTR mutant and WT
CFTR. The absence of these interactions could be very impor-
tant for the design and implementation of therapeutics. These
findings demonstrate that the F508 mutation has the poten-
tial to disrupt the CFTR and ENaC link, a disruption that may
account for the observed hyperabsorption of sodium in CF air-
ways. Thus, correcting the trafficking of this mutant, while
allowing for proper chloride transport, may still not fix the
sodium transport problem. Perhaps proper trafficking of the
mutant will not be sufficient to correct the pathophysiology of
the end stage lung disease found in CF. More acutely, perhaps
measures of ENaC function as noted by the effect of amiloride
on the nasal potential difference should be an important vari-
able examined during clinical trials of CFTR correction.
If we are to believe both the FRET and the co-IP data in this
study, it is possible that F508-CFTR reduces the distance
between the N terminus of CFTR and the C terminus of ENaC
subunits but that there is a physical interaction through
another domain that allows for a positive co-IP signal. We
tested this possibility with the rescue of the F508-CFTR traf-
ficking defect by low temperature and chemical correctors.
This resulted in an increase in the efficiency of energy transfer
between F508-CFTR and ENaC subunits (Fig. 5 and supple-
mental Figs. S4–S6). Because the correctors help release
F508-CFTR from ER retention, the positive FRET signal with
rescue suggests that the interaction takes place after the chan-
nels are trafficked from the ER. At the same time, the presence
of FRET signal suggests close proximity of the two proteins; it
does not, however, distinguish the presence (or the absence) of
the functional coupling between the rescued F508-CFTR and
ENaC (38). Future experiments will need to examine other
mutants of CFTR, such as those that traffic to the membrane
but are electrophysiologically quiescent, such as the
G551D-CFTR.
Although we were able to observe a FRET signal between
F508-CFTR and ENaC subunits following low temperature
and chemical rescue of F508-CFTR, they were considerably
lower compared with FRET measurement between WT CFTR
and ENaC subunits (6). These results suggest that even when
the folding and trafficking of the F508-CFTR are corrected,
the interaction with ENaC subunits is not fully restored. This
may be suggestive of an impaired functional interaction
between the two; however, published work regarding the con-
sequences of theF508-CFTR correction are complex (39) and
not only can lead to partial restoration of CFTR-mediated Cl
transport but may also affect the amiloride-sensitive current
(40, 41). However, contradictory data are presented, with cer-
tain studies suggesting that whenF508-CFTR is properly traf-
ficked by low temperature rescue, ENaC function is only cor-
rected if F508-CFTR is potentiated with genistein (42),
whereas others suggest that with recovery using chemical chap-
erones, such as sodium 4-phenylbutyrate, the F508-CFTR is
unable to regulate ENaC function, both in vitro (38) and in vivo
as measured by the nasal potential difference response to
amiloride (23, 26). Contrast this with in vivo results garnered by
correcting a stop mutation of CFTR, which in theory folds
properly and traffics without difficulty, where there is a signif-
icant correlation between the change in amiloride-sensitive
nasal potential difference and recovery of CFTR function in the
nasal epithelia (43). These data taken together would reiterate
that F508-CFTR has a different functional relationship from
WT CFTR, as captured by the differences in our FRET
efficiencies.
It may also be important to determine what led to the eleva-
tion of the negative control signal with the use of Corr3a/4a.
Both Corr3a and Corr4a have been shown to improve the fold-
ing and trafficking of F508-CFTR (30); it is noteworthy that
Corr4a has shown more specificity for correction of F508-
CFTR than Corr3a (30). One possibility is that the elevation of
negative control signal may indicate some potential off-target
specificities of the correctors because folding and trafficking is
a complex andmultistep process; further studies will be needed
to address this. Another possibility is that these correctors are
capable of causing artificial cross-linking or complexing of the
free fluorescent proteins, bringing them into close enough
proximity to cause a positive FRET signal. This is very plausible
because both the positive control of the fused YFP/CFP and the
free floating YFP/CFP increase by approximately equivalent
amounts (5%), as shown in Fig. 5C. Unlike our transport pro-
teins, the FRET controls are not restricted to the membrane,
and thus it is possible that these small molecule correctors are
able to force the control fluorophores to complex in a manner
in which the tethered transport protein tags are unable to.
Regardless, the data clearly establish that with correction there
is statistically significant FRET between F508-CFTR and
ENaC subunits. Further, it is noteworthy that our study has
been carried out in a model system with recombinant F508-
CFTR and ENaC subunits; it remains to be explored if the same
is true in in vivo circumstances. In synopsis, WT CFTR and
ENaC subunits interact at the plasmamembrane and internally,
F508 CFTR and ENaC Link
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as evidenced by our prior FRET studies. This study establishes
that althoughF508-CFTR andENaC subunits appear to inter-
act directly via co-IP, their cytoplasmic tails do not FRET intra-
cellularly and only weakly FRET when trafficking is corrected.
This regulation of Na transport, following the F508-CFTR
correction, probably occurs directly; however, our results can-
not exclude the possibility of a role for an adaptor protein(s) in
this association. Future work will need to examine which
domains of these proteins are mediating this interaction and
assess the nature of this interaction under dynamic conditions,
such as when either transport protein is activated or inhibited.
Understanding the structural and kinetic nature of this interac-
tion may be critical to better managing the airway pathology
that is the current life-limiting factor in patients afflicted with
CF.
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